LOW DOSE NALTREXONE
What is Naltrexone?
Naltrexone is an opiate receptor antagonist. The 50mg dose of Naltrexone was approved by the FDA for opioid and alcohol addiction in 1984. At much lower doses (0.5-9mg per day), it may provide relief to patients suffering from autoimmune diseases, chronic pain, mental health diseases, and inflammation.
Low Dose Naltrexone vs. Ultra-Low Dose Naltrexone:
Ultra-Low Dose Naltrexone (ULDN) is typically doses between one and ten micrograms (mcg). Low Dose Naltrexone (LDN) includes milligram (mg) doses from 0.5 mg – 4.5 mg.
Who is a good candidate for Low Dose Naltrexone?
• LS (Lou Gehrig’s Disease)
• Addiction
• Addison’s Disease
• Alopecia Areata
• Alzheimer’s Disease
• Amyotrophic Lateral Sclerosis
• Ankylosing Spondylitis
• Anxiety
• Atopic Allergy
• Atopic Dermatitis
• Autism Spectrum Disorders
• Bechet’s Disease
• Benign Prostatic Hypertrophy (BPH)
• Brain Fog
• COPD
• CREST Syndrome
• Celiac Disease
• Chronic Fatigue Syndrome
• Complex Regional Pain Syndrome
• Crohn’s Disease
• Depression
• Dermatomyositis
• Diabetes Mellitus Type I
• Eczema
• Ehlers-Danlos Syndrome
• Endometriosis
• Fibromyalgia
• General Anxiety Disorder
• Granulomatosis
• Graves Disease
• HIV/AIDS
• Hailey-Hailey Disease
• Hashimoto’s Disease
• Hypothyroidism
• Irritable Bowel Syndrome (IBS)
• Kawasaki’s Disease
• Lupus
• Lyme Disease
• Menier’s Disease
• Migraine Headaches
• Multiple Sclerosis (MS)
• Obsessive Compulsive Disorder (OCD)
• Pandas Disease
• Parkinson’s Disease
• Pediatrics
• Pemphigoid
• Periodontal Disease
• Polycystic Ovary Syndrome (PCOS)
• Post-Traumatic Stress Disorder (PTSD)
• Primary Lateral Sclerosis (PLS)
• Psoriasis
• Psoriatic Arthritis
• Restless Leg Syndrome
• Rheumatoid Arthritis
• SIBO
• Sarcoidosis
• Scleroderma
• Sjogren’s Syndrome
• Stiff Person Syndrome (SPS)
• Transverse Myelitis
• Ulcerative Colitis
• Wegener’s
• Weight Loss
• Women’s Health
• Vitiligo
Dosing Guidelines
It is critical to work with a provider or an accredited compounding pharmacy knowledgable in strategies that can help ensure success in using LDN. Optimal dosing is ultimately patient specific. Some patients find success very quickly, while others need to try a variety of dosing strategies while working closely with their provider and pharmacist.
To start out, we offer two different LDN capsule titration kits. Each kit increases the dose slowly by only 0.5 mg each week, until the patient’s therapeutic dose is reached. These titration kits range from either 0.5-4.5 mg or 1.5-4.5 mg of Naltrexone. Please consult with your health care provider to determine the best plan for you.
In addition to capsules, LDN can also be compounded into a flavored oral suspension (almond, olive, and MCT oil bases) as well as a transdermal cream (various cream bases available.
Low Dose Naltrexone vs. Ultra-Low Dose Naltrexone:
Ultra-Low Dose Naltrexone (ULDN) is typically doses between one and ten micrograms (mcg). On the other hand, Low Dose Naltrexone (LDN) includes milligram (mg) doses from 0.5 mg – 4.5 mg.
Learn More
